Literature DB >> 9862346

Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis.

Y Tagawa1, S Kakuta, Y Iwakura.   

Abstract

Concanavalin A (Con A)-induced hepatitis is an experimental hepatitis model in which hepatic injury is caused by the action of cytokines produced by T cells. Using IFN-gamma-deficient mice, we previously demonstrated that IFN-gamma plays a central role in Con A-induced hepatitis. Here, we show that development of the disease is completely suppressed in gld/gld mice, in which Fas ligand is defective. In contrast, suppression of the disease in Ipr/Ipr mice was incomplete, since a small amount of the fas mRNA was produced in these mice. The data indicate that activation of the Fas/Fas ligand system is a necessary step in the development of Con A-induced hepatitis. Furthermore, we found that not only fas but also caspase-1 expression was reduced in IFN-gamma-deficient mice. Since caspase-1 is an integral component of Fas signal transduction, these observations suggest that IFN-gamma-induced activation of both fas and caspase-1 expression causes enhancement of hepatocyte apoptosis resulting in the development of hepatitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862346     DOI: 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.0.CO;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis.

Authors:  A Trautmann; M Akdis; D Kleemann; F Altznauer; H U Simon; T Graeve; M Noll; E B Bröcker; K Blaser; C A Akdis
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.

Authors:  Meiqing Shi; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Role of 2B4-mediated signals in the pathogenesis of a murine hepatitis model independent of Fas and Valpha14 NKT cells.

Authors:  Hiroshi Furukawa; Hiroshi Kitazawa; Izumi Kaneko; Mitsunobu Matsubara; Masato Nose; Masao Ono
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

Review 4.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

5.  Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice.

Authors:  H Hentze; F Gantner; S A Kolb; A Wendel
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.

Authors:  K Seino; Y Setoguchi; T Ogino; N Kayagaki; H Akiba; H Nakano; H Taniguchi; Y Takada; K Yuzawa; T Todoroki; Y Fukuchi; H Yagita; K Okumura; K Fukao
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

7.  Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection.

Authors:  M Chen; M Sällberg; S N Thung; J Hughes; J Jones; D R Milich
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 8.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

9.  Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

Authors:  Akihiro Hasegawa; Xin Cheng; Kiichi Kajino; Alan Berezov; Kaoru Murata; Toshinori Nakayama; Hideo Yagita; Ramachandran Murali; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

Review 10.  Immune cell-mediated liver injury.

Authors:  Nadia Corazza; Anastasia Badmann; Christoph Lauer
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.